McIver Zachariah, Chief Medical Officer of Janux Therapeutics ($JANX), made one open market sale of company shares in the last 365 days, totaling about $37,300. His most recent sale occurred on January 2, 2026. These sales rank 10,664th among nearly 12,000 individual insiders, compared to an average sale amount of $8.6 million across 6.4 transactions. He reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Janux Therapeutics, Inc. | $JANX | McIver Zachariah | Chief Medical Officer | S | Common Stock | 2714 | $13.73 | 23,286.0000 | 62,023,685 | 10.44% | 0.00% |
| Jan. 2, 2026 | Janux Therapeutics, Inc. | $JANX | McIver Zachariah | Chief Medical Officer | A | Common Stock | 29000 | $0.00 | 52,286.0000 | 62,023,685 | 124.54% | 0.05% |
| Jan. 2, 2026 | Janux Therapeutics, Inc. | $JANX | McIver Zachariah | Chief Medical Officer | A | Stock option (right to buy) | 101500 | $0.00 | 101,500.0000 | 62,023,685 | 9999.99% | 0.16% |
| Jan. 2, 2025 | Janux Therapeutics, Inc. | $JANX | McIver Zachariah | Chief Medical Officer | A | Common Stock | 26000 | $0.00 | 26,000.0000 | 53,751,480 | 9999.99% | 0.05% |
| Jan. 2, 2025 | Janux Therapeutics, Inc. | $JANX | McIver Zachariah | Chief Medical Officer | A | Stock option (right to buy) | 91000 | $0.00 | 91,000.0000 | 53,751,480 | 9999.99% | 0.17% |